Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BiomX Inc. Director's Dealing 2020

Mar 27, 2020

35099_dirs_2020-03-27_0fc7ef75-b284-4a1f-bd6a-2cbad9e8b390.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2020-03-25

Reporting Person: GROSSMAN JONAS (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-03-25 Common Stock Options - Right to Buy $6.21 A 16000 Acquired 2030-03-25 Common Stock (16000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.0001 6500 Direct
Common Stock, par value $0.0001 1707500 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $11.5 2024-10-28 Common Stock (50129) 50129 Direct

Footnotes

F1: Consists of shares of common stock owned by Chardan Investments, LLC, for which Mr. Grossman is the managing member. Mr. Grossman disclaims beneficial ownership of the shares except to the extent of his pecuniary interest in the shares.

F2: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.